INTERNATIONAL PATENT: AQEMIA FILES APPLICATION FOR "3-(1H-INDAZOL-3-YL)ISOQUINOLINE DERIVATIVES AS MAP4K1 (HPK1) INHIBITORS AND USE THEREOF IN THERAPY"

GENEVA, Dec. 15 -- AQEMIA (231 RUE SAINT-HONORE75001 PARIS) filed a patent application (PCT/EP2025/065398) for "3-(1H-INDAZOL-3-YL)ISOQUINOLINE DERIVATIVES AS MAP4K1 (HPK1) INHIBITORS AND USE THEREOF IN THERAPY" on Jun 03, 2025. With publication no. WO/2025/252767, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GENEVOIS-BORELLA, Arielle (c/o AQEMIA231 rue Saint-Honore75001 PARIS France), TAYLOR, Corey (c/o AQEMIA231 rue Saint-Honore75001 PARIS France), GEORGE, Nicolas (c/o AQEMIA 231 rue Saint-Honore75001 PARIS), CHAMAYO...